Malignant middle cerebral artery infarct: A clinical case report by Leung, Kwan Yee (Queenie) et al.
Australasian Journal of Neuroscience  Volume 28 ● Number 1 ● May 2018 
 5 
Introduction: 
 
Malignant middle cerebral artery infarction 
(MMCAI) is the worst form of ischaemic 
stroke as it involves an infarction of nearly the 
whole middle cerebral artery (MCA) territory 
(>50% of the MCA territory on Computed To-
mography [CT]). MMCAI is also characterised 
by a reduction in blood supply of >66% to-
gether with a large area of dead tissue on CT 
(infarct volume of >82 mL within 6 hours of 
onset on MRI and infarct volume of >145mL 
within 14 hours of onset on MRI) (Huttner & 
Schwab, 2009; Oppenheim et al., 2000; Tho-
malla et al., 2003; Vahedi, Vicaut, et al., 
2007) which is usually reflected in significant 
motor deficits resulting in an inability to move 
independently. MMCAI is the most severe 
form of stroke and comprises up to 10% of all 
MCA territory infractions (Hacke et al., 1996); 
the annual incidence is 10-20 per 100,000 
people (Treadwell & Thanvi, 2010). Unwant-
ed sequela is space-occupying oedema lead-
ing to rapid neurological deterioration, irre-
versible coma and death. The prognosis is 
generally poor, and death occurs in approxi-
mately 80% of cases as a result of transtento-
rial herniation and brainstem compression 
(Back, Nagaraja, Kapur, & Eslick, 2015).  
 
Treatment options include intravenous (IV) 
thrombolysis within 4.5 hours of stroke onset, 
endovascular clot retrieval (ECR) within 24 
hours of stroke onset and surgical decom-
pressive surgery.  
 
 
 
 
 
 
 
Abstract 
 
Background: 
Ischaemic stroke accounts for 87% of strokes and occurs when a clot or a thrombus blocks a blood 
vessel, cutting off blood flow to a part of the brain. If large areas of brain are affected, space-
occupying oedema may result, leading to rapid neurological deterioration, coma and death. Malig-
nant middle cerebral artery infarction (MMCAI) is a life-threating ischaemic stroke involving the 
whole middle cerebral artery (MCA) territory and comprises up to 10% of MCA infarctions.  
 
Methods: 
We report the case of a 62 year old female ‘Mary’ who presented with a MMCAI together with a 
summary of the most recent and relevant evidence for treatment options in terms of survival and 
quality of life for her. We also focus on the vital role of the nurse in Mary’s care and treatment.  
 
Results:  
Intravenous thrombolysis and endovascular clot retrieval (ECR) during the hyperacute phase have 
been shown to improve outcomes but Mary did not meet the criteria for thrombolysis and received 
unsuccessful ECR. Her neurological condition deteriorated so she underwent surgical decompres-
sion, which is one of the major advances for MMCAI treatment together with expert neuro critical 
care nursing. Mary made a good functional recovery, returning home to live independently. 
 
Conclusion: 
This case highlights the need to consider all contextual and patient preferences in relation to treat-
ment options. In addition the case emphases the vital role the neuro critical care nurse specialist 
plays in the complex assessment and treatment of this patient who experienced a MMCAI and un-
derwent complex interventions.  
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Significant studies have shown that early de-
compressive craniectomy (DC) in patients 
aged <60 years within 48 hours of onset of 
malignant stroke have significantly reduced 
mortality (22% versus 71% – pooled analysis; 
numbers needed to treat =2) (Vahedi, Hof-
meijer, et al., 2007); however, the efficacy of 
this treatment on functional outcome is incon-
clusive. 
 
This paper provides a summary of selected 
published studies of relevant current treat-
ment options for a patient who presented with 
malignant MCA infarct. Using the case study 
as an example, current treatment options 
including thrombolysis, ECR and DC are ex-
amined together with the research evidence 
for these treatments. In addition the vital role 
of the neuro critical care nurse specialist is 
highlighted.  
 
Case Study 
 
This case study follows Mary’s (a pseudo-
nym) journey from the time when her daugh-
ter found her collapsed on the floor in her 
home to the day she was discharged from 
the hospital. For the purposes of this paper, 
the clinical guideline used at the metropolitan 
tertiary referral facility (location of a hypera-
cute stroke service) in which Mary was treat-
ed (in Australia) was used as a framework. 
Mary gave written consent for the publication 
of this paper. 
 
Presentation and health history 
 
Mary, a 62 year old female, was found by her 
daughter at 03:45 on the bathroom floor of 
her home. Her daughter stated that Mary was 
apparently well when she last saw her before 
bed time at approximately 22:00. An ambu-
lance was called and on examination, Mary 
had a left sided facial droop, gaze palsy, left 
visual neglect, dense left hemiparesis and 
sensory neglect. She was immediately trans-
ported to the nearest hospital but later was 
transferred to the tertiary referral facility (a 20
-30 minute drive), a thrombolysis centre of 
the local health district for hyperacute stroke 
management. Ninety minutes after being 
found by her daughter Mary was screened for 
the use of thrombolysis. Mary presented to 
the tertiary referral facility outside of the 
thrombolysis treatment window (that is >4.5 
hour after stroke onset). She had a history of 
atrial fibrillation and aortic and mitral metallic 
valve replacements on warfarin 
(anticoagulant); hypertension managed with 
olmesartan/hydrochlorothiazide (a combina-
tion of angiotensin II receptor blocker and 
diuretic); and dyslipidaemia treated with 
simvastatin (lipid lowering).  
 
On arrival, Mary was haemodynamically sta-
ble despite the presence of atrial fibrillation. 
All standard investigations were carried out 
according to the clinical guideline for stroke 
management including rapid clinical assess-
ment, recommended imaging: plain CT brain 
scan, CT angiogram and CT perfusion, and 
blood tests (Stroke Foundation, 2017). At this 
time Mary’s clinical assessment revealed a 
National Institute of Health Stroke Scale 
(Brott et al., 1989) score of 19, which corre-
lates with ‘severe stroke’.  
Figure 1. Computerised tomography scan 
 
An urgent CT scan showed a loss of grey-
white matter differentiation in the right insular 
cortex, the inferior aspect of the right frontal 
lobe, at the right temporal lobe and inferior 
aspect of the right parietal lobe (Figure 1); 
the CT angiogram revealed an occlusion of 
the right proximal M2 artery. In addition, CT 
perfusion findings consistent with an estab-
lished infarct involving the right insula, inferior 
aspect of the right frontal lobe and anterior 
right temporal lobe were present. There ap-
peared to be a moderate to large penumbra 
associated with the infarct (Figure 2). Her 
serum International Normalised Ratio (INR) 
was subtherapeutic (1.5); this indicated an 
inadequate anticoagulation to prevent compli-
cations related to her metallic valves and her 
serum creatinine level of 167umol/L revealed 
a degree of renal impairment. 
 
Treatment during the hyperacute phase 
 
Mary presented to the tertiary referral facility 
outside of the thrombolysis treatment window 
(that is >4.5 hour after stroke onset). Until 
recently, IV tissue plasminogen activator 
(tPA) was the only medical therapy approved 
Australasian Journal of Neuroscience  Volume 28 ● Number 1 ● May 2018 
 7 
for the treatment of stroke during the hypera-
cute stage (<4.5 hours from onset of stroke 
symptoms). Approximately one third of the 
patients treated with IV tPA alone achieve full 
recovery (Hacke et al., 2008).  
 
A meta-analysis from nine randomised con-
trolled trials (RCTs) (n=6756) found that the 
earlier patients began thrombolysis with al-
tepase, the better the outcome (Emberson et 
al., 2014). A good outcome is defined by a 
modified Rankin Score (mRS) (Rankin, 1957) 
of 0-1 (i.e. symptom free with no loss of func-
tion) at 3-6 months. Three different altepase 
treatment sub-categories based on time from 
symptom onset were altepase administered: 
within the first 3 hours of onset; between 3 
hours to 4.5 hours of onset; and between 4.5 
hours to 6 hours of onset. Within these three 
sub-categories: 1549 patients received al-
tepase within the first 3 hours of onset had a 
good outcome 32.9% versus 23.1% (OR 1.75 
95% CI 1.35-2.27); 2768 patients who re-
ceived altepase after 3 hours of onset but 
within 4.5 hours had a good outcome 35.3% 
versus 30.1% (OR 1.26 95% CI 1.05-1.51); 
and 2394 patients found that patients who 
received alteplase more than 4.5 hours of 
onset but within 6 hours had a good outcome 
32.6% versus 30.6% (OR 1.15, 95% CI 0.95-
1.40) (Emberson et al., 2014). Results 
showed that 5024 patients 80 years or 
younger who had a good outcome was 
39.4% versus 33.9% (OR 1.25 95% CI 1.10-
1.42) who did not (Emberson et al., 2014). Of 
the 1729 patients older than 80 years, 17.6% 
had a good outcome and 13.2% did not (OR 
1.56 95% CI 1.17-2.08) (Emberson et al., 
2014). Therefore a widely accepted recom-
mendation for the treatment of stroke is IV 
tPA (0.9mg/kg, maximum dose 90mg) to be 
administered within 3 hours of onset of is-
chemic stroke (Class I, Level of Evidence 
A )’ (Powers et al., 2018).  
 
Thrombolysis should commence as early as 
possible (within three hours) after stroke on-
set but may be used up to 4.5 hours after 
onset (Wardlaw, Murray, Berge, & del Zoppo, 
2014). The complications of IV thrombolysis 
including intracranial haemorrhage and angi-
oedema (Emberson et al., 2014; Powers et 
al., 2018) are significant and must be consid-
ered on an individual basis.  
 
The time of her onset of stroke to the time 
she was assessed in the emergency room 
was seven and a half hours, which was still 
within the ECR treatment window (24 hours 
from stroke onset) (Nogueira et al., 2018). 
Current stroke guideline states that undergo-
ing ECR is beneficial beyond six hours of 
stroke onset if a CT angiogram shows a large 
vessel occlusion (LVO) (Stroke Foundation, 
2017). After Mary’s son provided informed 
consent for the procedure, ECR for recanali-
zation was performed. Recent trials have 
shown that ECR significantly improves func-
tional independence in patients with a large 
vessel occlusion, a large CT perfusion mis-
match and a good collateral circulation 
(Lambrinos et al., 2016).  
 
A meta-analysis of five major trials revealed 
that ECR led to significantly reduced disabil-
ity at 90 days compared with control 
(adjusted cOR 2.49, 95% CI 1.76–3.53; 
p<0.0001) (Goyal et al., 2016). The number 
needed to treat with ECR to reduce disability 
by at least one mRS level was 2.6 (Goyal et 
al., 2016). As a result of these impressive 
outcomes, the current American Heart Asso-
ciation/American Stroke Association recom-
mends that patients should receive ECR if 
they meet the criteria (Class I, Level of Evi-
dence A) (Powers et al., 2018) which in-
cludes stroke symptoms within 24 hours of 
onset or time last known well in wake-up 
stroke; a non-contrast CT without a large in-
farct (>1/3 MCA territory) or haemorrhage; 
and a CT angiogram (aortic arch to vertex of 
the brain) showing a large vessel occlusion of 
the internal carotid artery, M1 (first segment) 
or proximal M2 branches of the MCA or the 
basilar artery (Lambrinos et al., 2016; Powers 
et al., 2015). Mary’s MMCAI was extensive 
 
 
Figure 2. Computerised tomography perfusion scan 
Australasian Journal of Neuroscience  Volume 28 ● Number 1 ● May 2018 
 8 
and she met many of these criteria i.e. a 
moderate to large penumbra associated to 
infarct and an occlusion of right M2 artery. 
 
After the ECR, Mary was admitted to the neu-
rosurgical Intensive care unit for more contin-
uous monitoring of her condition. Neurologi-
cally she was alert. Her GCS after the ECR 
was 13/15 (Eye opening=3, Verbal re-
sponse=4, Motor response=6) and her Na-
tional Institute of Health Stroke Scale score 
was 15 (Answers both questions incorrectly 
=2, partial facial palsy=2, no movement on 
left arm=4, no effort against gravity on left 
left=3, partial sensory loss=1, severe apha-
sia=2, and partial neglect=1). Her respiratory 
function was good; she was maintaining her 
own airway and was breathing without diffi-
culty. Haemodynamically she was stable; 
normotensive without support with vasoactive 
medication, despite atrial fibrillation (heart 
rate: 65-105bpm) and she was normother-
mic.  
 
Day 1 after the stroke, a repeat CT scan re-
vealed an acute cortical and intraparenchy-
mal haemorrhage involving the right cerebral 
hemisphere with moderate marked mass ef-
fect. The infarction may increase in size dur-
ing the acute phase causing clinical deterio-
ration resulting from raised intracranial pres-
sure (ICP) and tentorial herniation 
(Neugebauer et al., 2016). Conservative 
medical management, including hyperventila-
tion, mannitol and sedation aiming to reduce 
oedema and mass effect in malignant MCA 
infarctions is considered minimally effective 
with associated high mortality (Powers et al., 
2018) so this was not a treatment option. A 
DC procedure was therefore considered.  
 
A family conference was led by the neurology 
medical team and facilitated by the neuro 
critical care nurse specialist. The neurology 
consultant explained to the family that Mary 
was likely to deteriorate as there was evi-
dence of haemorrhagic transformation and 
swelling. In addition, the team explained the 
controversy and uncertainty regarding DC, 
especially in Mary’s age group. They were 
careful to discuss the likelihood that the pro-
cedure would increase her chances of surviv-
al but would not necessarily reverse her cur-
rent neurological deficits and that many pa-
tients in a similar condition are then depend-
ent on others afterwards. The nurse encour-
aged the family to share information about 
Mary: her wishes, perspective on life and cur-
rent quality of life. The family was informed 
that DC is a major operation requiring pro-
longed treatment in intensive care, including 
mechanical ventilation and its associated 
risks. In particular the need to reverse Mary’s 
anticoagulation was a concern (risk of recur-
rent stroke was high as she had a metallic 
mitral valve and was in AF). A neurosurgical 
opinion to explore this treatment option was 
offered and the neurosurgical team was con-
sulted. The family were of the opinion that 
Mary would have considered her functional 
deficit and dependence on others acceptable. 
The family provided informed consent for DC 
surgery if her neurological condition deterio-
rated.  
 
Forty-two hours after the onset of stroke 
symptoms Mary’s level of consciousness de-
creased (GCS 12 i.e. Eye opening=2, Verbal 
response=4, Motor response=6) and the neu-
rosurgical team was immediately notified. 
Mary underwent a DC soon afterwards. 
 
Three initial RCTs conducted in Europe re-
vealed an excellent to favourable outcome for 
early DC for MCI for patients younger than 60 
years (absolute risk reduction in mortality of 
50% with 43% of survivors able to walk at six 
months) (Vahedi, Hofmeijer, et al., 2007). 
However, three recent RCTs in which pa-
tients >60 years were included reported 
worse outcomes for early DC for MCI. None 
of the older patients achieved an excellent 
functional outcome (mRS 0-2) and very few 
patients reached mRS 3 (Streib, Hartman, & 
Molyneaux, 2016). An Absolute Reduction 
Incidence (ARI) of 4% and numbers needed 
to treat 25 indicates favourable outcomes 
and for unfavourable outcomes, the ARI was 
32.5% and numbers needed to treat was 3.1 
(Streib et al., 2016). The decision to proceed 
with DC in Mary’s case was based on the 
knowledge that it would likely improve her 
chances of survival but not necessarily her 
functional recovery together with information 
provided by the family.  
 
The contemporary philosophy of nursing en-
compasses a holistic view of the person in 
order to deliver patient centred care 
(McCormack, 2003); nurses are required to 
know the patients’ and their carers’ perspec-
tives on life. Quality of life (QoL) studies had 
been conducted and three major outcomes 
including functional status, depression and 
QoL have been explored after DC (Green, 
Demchuk, & Newcommon, 2015; McKenna, 
Wilson, Caldwell, & Curran, 2012; Middelaar, 
Nederkoorn, Worp, Stam, & Richard, 2015; 
Rahme, Zuccarello, Kleindorfer, Adeoye, & 
Ringer, 2012). Main assessment tools used 
to assess functional outcomes include the 
modified Rankin Scale (mRS) and Barthel 
Index (BI) (Green et al., 2015; Rahme et al., 
2012) and the Zung Self-Rating Depression 
Scale and Hospital Anxiety and Depression 
scale (HADS) were used to assess depres-
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sion outcome (McKenna et al., 2012; Rahme 
et al., 2012). Questionnaires or visual analog 
scale were used to assess QoL outcomes 
(Middelaar et al., 2015). 
 
Of note in a study examining functional out-
come between 3-114 months (mean: 19 
months) after experiencing a stroke ( n= 156,  
mean age: 50), moderate disability (mRS 4) 
was reported in 46%, severe disability was 
reported in 10% and a further 41% had some 
disability (mRS (Rahme et al., 2012). In 
the same study depression was reported in 
56%. and over 76% of patients were satisfied 
with life (Rahme et al., 2012) Many patients 
in these studies state that they would consent 
again for DC (Green et al., 2015; McKenna et 
al., 2012; Rahme et al., 2012).  
 
Based on these results MMCAI patients after 
DC appear to experience moderate to severe 
disability and varying degrees of depression. 
One study showed some patients had a rela-
tively good mood as they were able to main-
tain close relationships with families and 
friends, whereas others experienced depres-
sion (Green et al., 2015; Rahme et al., 2012) 
because of their inability to return to their pre-
illness function and lifestyle. Other frequent 
findings include neuropsychological impair-
ments (McKenna et al., 2012), alterations in 
personality and loss of independence (Green 
et al., 2015). 
 
However, the findings for QoL and patient 
satisfaction showed that despite their physi-
cal disability, their QoL and satisfaction with 
life remained high. One study stated that pa-
tients reported only a small decrease in QoL 
long term (7-51 months) when compared to 
the general population (Middelaar et al., 
2015). This finding contradicted the neurosur-
geons or neurologists’ perceptions that pa-
tients had a poorer QoL due to severe disa-
bility after DC. The review suggested that 
patients had better coping mechanisms than 
previously thought, despite their poor physi-
cal functioning and dependence on others for 
the activities of daily living (Middelaar et al., 
2015). This may have been a result of re-
sponse shift (a recalibration in the perception 
of QoL over time after experiencing a disabil-
ity). Regardless, clinical guidelines for stroke 
management recommend that DC is offered 
to all MMCAI patients if extensive discussion 
about the risks and benefits is undertaken 
(Stroke Foundation, 2017). 
 
Intra-operatively, there were signs of vaso-
paralysis in Mary’s brain but later pulsation 
returned. Four burrholes and a large craniot-
omy were performed (and two parts of skull 
bone were inserted in a fat pouch in her ab-
dominal cavity). In order to monitor ICP, an 
intraparenchymal catheter was inserted 
(Codman EXPRESS® Monitoring System). 
Mary experienced episodes of asystole and 
long cardiac sinus pauses but these resolved 
without the need for treatment. 
 
Early recovery and rehabilitation after de-
compressive craniectomy: 
 
Mary was admitted to neurosurgical intensive 
care unit after DC. Supportive care and treat-
ment of acute complications were estab-
lished. Her assessment findings indicated 
that she was breathing without difficulty or 
the assistance of an artificial airway or respir-
atory support other than 2L/min of oxygen via 
nasal cannula and was haemodynamically 
stable (systolic pressure: 100-140mmHg). 
Her neurological assessment revealed that 
her eyes opened to voice, she obeyed com-
mands although she was confused (GCS 
13/15: E=3, V=4, M=6). She had normal pow-
er in her right arm and leg but mild weakness 
in her left arm and leg. Her pupils were equal 
and reacting briskly to light. A repeat CT 
brain scan showed an increase in the acute 
haemorrhage. There was also some slight 
worsening of the mass effect and midline 
shift with a slight increase in uncal herniation 
(Figure 3). 
 
Figure 3. Repeat Computerised tomography 
scan after the decompressive craniectomy 
(DC)  
 
She was enterally fed via a nasogastric tube 
(NGT). Mary developed deep vein throm-
bosis (DVT) and she was anaemic 
(haemoglobin (Hb): 79 g/L). She was treated 
with intravenous heparin and an iron infusion. 
Both the medical and nursing team regularly 
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provided updates of Mary’s progress to her 
family. 
 
 The goal of post-operative care was to 
prevent or minimize complications related to 
anaesthesia and the surgical procedure. The 
focus was on smooth and timely emergence 
from anaesthesia while optimizing haemody-
namic, respiratory and electrolyte conditions 
(Bose & Luoma, 2017; Liddle, 2013). This is 
vital to ensure adequate brain perfusion and 
healing because postoperatively the body 
undergoes significant physiological stress 
that may be manifested as fluctuations in ho-
meostasis. This stress state is modulated by 
changes in sympathetic tone that controls 
body temperature and vascular tone 
(Tsaousi, Pourzitaki, & Bilotta, 2017).  
 
Neurosurgical procedures have an overall 
complication rate of 14.3% (Badenes, Prisco, 
Maruenda, & Taccone, 2017). Moreover, pa-
tients have a high risk of experiencing neuro-
logical complications postoperatively and re-
quire advanced (ICP) neuromonitoring and 
frequent neurological assessment. deep vein 
thrombosis rates after craniectomy are as 
high as 34% (Nyquist et al., 2016). Current 
evidence supports combined mechanical and 
chemical thromboprophylaxis within 24 hours 
after surgery (Tsaousi et al., 2017). However, 
there is a higher risk of postoperative haem-
orrhage for patients who receive heparin 
(Wang et al., 2017). It is therefore important 
to monitor closely for signs of postoperative 
haemorrhage, particularly intracranial haem-
orrhage (ICH). Which can occur in 1-3% of 
cases with mortality rates as high as 30% 
(Siegemund & Steiner, 2015). Neuro critical 
care nurse specialists can positively affect 
the mortality rate by identifying signs of neu-
rological deterioration early, alerting the neu-
rosurgical team and preparing the patient for 
surgery. This is particularly important within 
the 24 hours after surgery when the risk of 
haemorrhage is greatest (Nittby, Maltese, & 
Ståhl, 2016).  
 
Comprehensive and frequent neurological 
assessments and vital sign observations are 
the cornerstones of post-operative neurosur-
gical care in the unit in which Mary was treat-
ed (Northern Sydney Local Health District, 
2009). In addition, Mary’s post-operative care 
included: 1) positioning the head of bed at 30 
degrees and not lying on the operative side; 
2) monitoring the scalp at the craniectomy 
site for a “boggy” appearance – oedema 
which is expected in the initial post –
operative period, due to CSF recirculation & 
wound healing; 3) assessing pain and giving 
analgesia; 4) meticulous wound care and 
checking daily for signs of infection; 5) check-
ing other surgical wound sites; 6) consulting 
with physiotherapy regarding the provision of 
a helmet to protect Mary’s brain until cranio-
plasty was performed 7) communicating with 
Mary in terms she could understand and on-
going communication with the family.  
 
Progress during treatment on the neurolo-
gy ward:  
 
Although Mary progressed well, she experi-
enced complications. She had some partial 
facial seizure activity which was controlled by 
the antiepileptic medication, Sodium 
Valproate. Her liver function tests were ele-
vated (thought to be an unwanted effect of 
the statin medication and paracetamol) and 
improved after withholding the statin and only 
administering paracetamol when required. 
Mary experienced hallucinations; the contrib-
uting factors were likely to be medication and 
illness-related but this was never clearly elu-
cidated. Nocturnal temazepam was given 
and the symptoms subsided. In addition, she 
had constipation resulting in overflow diar-
rhoea and abdominal pain which resolved 
after a fleet enema and regular aperients. 
 
Mary was reviewed by the rehabilitation team 
and enrolled in Stroke Acute Rehabilitation 
Therapy (START). She responded well to 
rehabilitation walking independently and 
managing to perform activities of daily living 
such as showering, dressing and cooking 
with minimal assistance.  
 
Cranioplasty (bone was reinserted in her cra-
nium) was performed 6 weeks after her crani-
ectomy and the wound healed well. Mary’s 
function improved and she was discharged 
home with few symptoms or deficits aside 
from mild left sided weakness and cognitive 
impairment. 
 
Conclusion 
 
This paper summarises the treatment journey 
for Mary, a 62 year old female who presented 
to our facility with MMCAI and the effective-
ness of both thrombolysis and ECR in im-
proving outcomes for patients who experi-
ence ischaemic stroke. Our examination of 
the evidence suggests that although life sav-
ing the functional outcome for DC varies and 
QoL differs. Our case report highlights the 
complexity in managing patients who experi-
ence MMCAI. It highlights the vital role the 
neuro critical care nurse specialist played in 
not only assessing, monitoring and treating 
Mary but also facilitating discussions and 
providing information and advice to her and 
her family prior to making the important deci-
sion to undergo DC. 
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